Cancer and Leukemia Group B

Cancer and Leukemia Group B (CALGB) is a clinical research organization focused on improving cancer treatment through clinical trials. Established in the 1950s, CALGB conducts studies to evaluate the effectiveness of new therapies, combinations of existing treatments, and supportive care for various cancers, including leukemia. The group consists of hospitals, researchers, and healthcare professionals collaborating to gather data that can lead to better patient outcomes. By analyzing results, CALGB aims to advance cancer care, ensuring that treatments are based on solid evidence and benefit patients' health and quality of life.